Home » Stocks » Edwards Lifesciences » Financials » Balance Sheet

Edwards Lifesciences Corporation (EW)

Stock Price: $83.20 USD -0.49 (-0.59%)
Updated Sep 18, 2020 4:00 PM EDT - Market closed

Balance Sheet (Annual)

Numbers in millions USD. Fiscal year is January-December.
Year2019201820172016201520142013201220112010200920082007200620052004200320022001200019991998
Cash & Equivalents1,17971481893071865442031117139633421914218317948.9061.1034.2047.7028.00--
Short-Term Investments338242519341506785517211279--8.1049.40---------
Cash & Cash Equivalents1,5179571,3381,2711,2251,43993752145139633422719118317948.9061.1034.2047.7028.000.000.00
Cash Growth58.59%-28.49%5.22%3.79%-14.88%53.57%79.69%15.74%13.73%18.56%47.31%18.62%4.6%2.35%265.24%-19.97%78.65%-28.3%70.36%---
Receivables599537479415372331335357345303272205145127119119119108101129155-
Inventory64160755539734029730928126120416615215314213212812111286.6087.00169-
Other Current Assets22718617815811216514513211113011710997.3079.6085.6071.5060.1065.8057.1057.0032.000.00
Total Current Assets2,9842,2872,5492,2402,0482,2311,7261,2921,1691,033889692586532514368360320292301356-
Property, Plant & Equipment1,140868680580483443422373304270252230228213202202210209188183226-
Long-Term Investments58650656753238024121.9021.1021.8025.0022.3014.7034.3020.2010.7020.6035.4023.5092.9098.001.00-
Goodwill and Intangibles1,5041,4551,595831834399419452417382402413473454475490419399402511839-
Other Long-Term Assets27420827632731220912283.5069.2057.5050.1050.9028.1028.2026.9032.6076.7052.507.8014.0015.000.00
Total Long-Term Assets3,5043,0373,1172,2702,0081,2929849308127357267087637157157457416846918061,081-
Total Assets6,4885,3245,6664,5104,0563,5232,7102,2221,9811,7671,6161,4001,3501,2471,2291,1131,1011,0049831,1071,437-
Accounts Payable87787777053347642634634732027451.1065.6063.9048.9060.70195184177184177156-
Current Debt25.50-598------41.80--150-----1.1061.00--
Other Current Liabilities0.000.0051.700.000.000.000.000.0015.4022.30239193166177134-195.40-184.1020.600.000.000.000.00
Total Current Liabilities9028771,420533476426346347335338291259380226194--198185238156-
Long-Term Debt653594438822597598593189150-90.3017661.70236316--246310367833-
Other Long-Term Liabilities78471385253648030722720615712176.8087.4073.0035.3028.800.000.0025.4029.8062.00-776.000.00
Total Long-Term Liabilities1,4371,3071,2901,3591,077906820395307121167263135271345--27134042957.00-
Total Liabilities2,3402,1832,7101,8911,5531,3321,166742643459458521515497539485466465524667213-
Total Debt6795941,03682259759859318915041.8090.30176212236316267256246311428833-
Debt Growth14.31%-42.71%26.04%37.76%-0.2%0.84%213.31%25.86%259.81%-53.71%-48.55%-17.1%-10.26%-25.37%18.35%4.42%4.2%-21.04%-27.36%-48.62%--
Common Stock5635841,127-1,089-651-550-459-13714.702262602372793314094254454413463368330.00
Retained Earnings3,7422,6951,9623,9063,3372,8422,0311,6541,3611,12490667754943430322422214387.70103418-
Comprehensive Income-156-139-133-198-183-101-27.60-37.90-37.50-42.10-7.90-35.407.50-15.80-22.20-20.80-32.20-44.7025.201.00-27.00-
Shareholders' Equity4,1483,1402,9562,6192,5032,1911,5441,4791,3381,3081,1588798357496906286355394594401,224-
Total Liabilities and Equity6,4885,3245,6664,5104,0563,5232,7102,2221,9811,7671,6161,4001,3501,2471,2291,1131,1011,0049831,1071,4370.00
Net Cash / Debt83836330144962884134433230035424451.30-20.50-53.10-138-218-195-211-263-400-8330.00
Net Cash / Debt Growth131.07%20.46%-32.91%-28.51%-25.32%144.53%3.52%10.66%-15.3%45.32%375.24%--61.39%-61.38%-36.98%12.07%-7.86%-19.72%-34.2%-51.98%--
Net Cash Per Share1.340.580.480.700.971.320.510.480.440.520.360.08-0.03-0.08-0.19-0.31-0.27-0.30-0.37-0.57--
Working Capital2,0821,4101,1291,7081,5721,8051,380945833695599433206305320--12210763.00200-
Book Value Per Share6.645.004.674.103.873.432.302.151.951.921.721.311.211.070.970.880.900.760.650.63--